Research Papers

25 of 234 papers

CSV Excel
Quick filters: Open Data Open Code Pre-registered Funding Declared COI Declared Open Access Clear Filters
Early decrease in blood platelet count is associated with poor prognosis in COVID-19 patients-indications for predictiv…
Zhao X; Wang K; Zuo P; Liu Y; Zhang M; Xie S; Zhang H; Chen X; Liu C.
EPMA J (Unknown)
Published: 2020
2/6 Transparent
Funding Declared
Label-free quantitative identification of abnormally ubiquitinated proteins as useful biomarkers for human lung squamou…
Lu M; Chen W; Zhuang W; Zhan X.
EPMA J (Unknown)
Published: 2020
2/6 Transparent
Funding Declared
Immunohistological staining of unknown chemokine RANTES/CCL5 expression in jawbone marrow defects-osteoimmunology and d…
Lechner J; Schulz T; von Baehr V.
EPMA J (Unknown)
Published: 2019
1/6 Transparent
Identification of clinical trait-related lncRNA and mRNA biomarkers with weighted gene co-expression network analysis a…
Li N; Zhan X.
EPMA J (Unknown)
Published: 2019
2/6 Transparent
Funding Declared
Signaling pathway network alterations in human ovarian cancers identified with quantitative mitochondrial proteomics.
Li N; Zhan X.
EPMA J (Unknown)
Published: 2019
2/6 Transparent
Funding Declared
Individualized metabolic profiling stratifies pancreatic and biliary tract cancer: a useful tool for innovative screeni…
Lee JH; Yu SE; Kim KH; Yu MH; Jeong IH; Cho JY; Park SJ; Lee WJ; Han SS; Kim TH; Hong EK; Woo SM; Yoo BC.
EPMA J (Unknown)
Published: 2018
2/6 Transparent
Funding Declared
Novel concept to guide systolic heart failure medication by repeated biomarker testing-results from TIME-CHF in context…
Davarzani N; Sanders-van Wijk S; Maeder MT; Rickenbacher P; Smirnov E; Karel J; Suter T; de Boer RA; Block D; Rolny V; Zaugg C; Pfisterer ME; Peeters R; Brunner-La Rocca HP; TIME-CHF investigators.
EPMA J (Unknown)
Published: 2018
3/6 Transparent
Registered Funding Declared
Individualised patient profile: clinical utility of Flammer syndrome phenotype and general lessons for predictive, prev…
Golubnitschaja O; Flammer J.
EPMA J (Unknown)
Published: 2018
2/6 Transparent
Funding Declared
The potential relationship between Flammer and Sjögren syndromes: the chime of dysfunction.
Baban B; Golubnitschaja O.
EPMA J (Unknown)
Published: 2017
Diseases potentially related to Flammer syndrome.
Konieczka K; Erb C.
EPMA J (Unknown)
Published: 2017
1/6 Transparent
Vitamin D in the prevention, prediction and treatment of neurodegenerative and neuroinflammatory diseases.
Koduah P; Paul F; Dörr JM.
EPMA J (Unknown)
Published: 2017
2/6 Transparent
Funding Declared
The BSSG rat model of Parkinson's disease: progressing towards a valid, predictive model of disease.
Van Kampen JM; Robertson HA.
EPMA J (Unknown)
Published: 2017
2/6 Transparent
Funding Declared
Acupuncture benefits for Flammer syndrome in individuals with inherited diseases of the retina.
Blechschmidt T; Krumsiek M; Todorova MG.
EPMA J (Unknown)
Published: 2017
1/6 Transparent
Traditional medicine as a potential treatment for Flammer syndrome.
Kikuchi A; Shiga Y; Takayama S; Arita R; Maekawa S; Kaneko S; Himori N; Ishii T; Nakazawa T.
EPMA J (Unknown)
Published: 2017
2/6 Transparent
Funding Declared
Identification of beta cell dysfunction at the pre-symptomatic stage of diabetes mellitus by novel analytical system: l…
Krapfenbauer K.
EPMA J (Unknown)
Published: 2017
Innovative payer engagement strategies: will the convergence lead to better value creation in personalized medicine?
Akhmetov I; Bubnov RV.
EPMA J (Unknown)
Published: 2017
2/6 Transparent
Funding Declared
Personalized approach in brain protection by hypothermia: individual changes in non-pathological and ischemia-related g…
Pastukhov A; Krisanova N; Maksymenko V; Borisova T.
EPMA J (Unknown)
Published: 2016
2/6 Transparent
Funding Declared
Discovery of biomarkers in rare diseases: innovative approaches by predictive and personalized medicine.
Gülbakan B; Özgül RK; Yüzbaşıoğlu A; Kohl M; Deigner HP; Özgüç M.
EPMA J (Unknown)
Published: 2016
2/6 Transparent
Funding Declared
The Berlin Treatment Algorithm: recommendations for tailored innovative therapeutic strategies for multiple sclerosis-r…
Veauthier C; Hasselmann H; Gold SM; Paul F.
EPMA J (Unknown)
Published: 2016
2/6 Transparent
Funding Declared
The role of testosterone in colorectal carcinoma: pathomechanisms and open questions.
Roshan MH; Tambo A; Pace NP.
EPMA J (Unknown)
Published: 2016
2/6 Transparent
Funding Declared
Status of stem cells in diabetic nephropathy: predictive and preventive potentials.
Baban B; Liu JY; Payne S; Abebe W; Yu JC; Mozaffari MS.
EPMA J (Unknown)
Published: 2016
2/6 Transparent
Funding Declared
Integration of suboptimal health status and endothelial dysfunction as a new aspect for risk evaluation of cardiovascul…
Kupaev V; Borisov O; Marutina E; Yan YX; Wang W.
EPMA J (Unknown)
Published: 2016
1/6 Transparent
Suppressed endothelin-1 by anti-VEGF therapy is important for patients with BRVO-related macular edema to improve their…
Kida T; Flammer J; Oku H; Morishita S; Fukumoto M; Suzuki H; Konieczka K; Ikeda T.
EPMA J (Unknown)
Published: 2016
2/6 Transparent
Registered
Prevention of fatigue and insomnia in shift workers-a review of non-pharmacological measures.
Richter K; Acker J; Adam S; Niklewski G.
EPMA J (Unknown)
Published: 2016
1/6 Transparent
Tear fluid biomarkers in ocular and systemic disease: potential use for predictive, preventive and personalised medicin…
Hagan S; Martin E; Enríquez-de-Salamanca A.
EPMA J (Unknown)
Published: 2016
2/6 Transparent
Funding Declared